Targeting the renin-angiotensin-aldosterone-system in atrial fibrillation: a shift from electrical to structural therapy?

By Choudhury Anirban   Varughese George I   Lip Gregory YH  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 13, 2005-10 ,pp. : 2193-2207

Informa Healthcare

Access to resources Recommend Favorite

Inflammation Fueling Atrial Fibrillation Substrate: Seeking Ways to “Cool” the Heart

By  

Medicinal Chemistry, Vol. 10, Iss. 7, 2014-11 ,pp. : 663-671

Bentham Science Publishers

Access to resources Recommend Favorite

The Use of Drugs for Cardioversion of Recent Onset Atrial Fibrillation and Flutter: Focus on Ibutilide

By Obel O.A.   Camm A.J.  

Drugs & Aging, Vol. 12, Iss. 6, 1998-06 ,pp. : 461-476

Adis International

Access to resources Recommend Favorite

Effect of the Cardioselective, Sarcolemmal K_ATP Channel Blocker HMR 1098 on Atrial Electrical Remodeling During Pacing-Induced Atrial Fibrillation in Dogs

By Vereckei András   Gögelein Heinz   Wirth Klaus   Zipes Douglas  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 1, 2004-01 ,pp. : 23-30

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Atrial Fibrillation and Flutter: Focus on Oral Dofetilide, a New Selective Class III Antiarrhythmic Agent

By  

Heart Drug, Vol. 1, Iss. 6, 2002-02 ,pp. : 320-331

Karger

Access to resources Recommend Favorite